{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:23:41Z","timestamp":1789014221447,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04009-8","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T09:00:06Z","timestamp":1744880406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Myopi-X lenses vs. low-dose atropine in myopia control: a Turkish retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Nilay","family":"Akagun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur Emrah","family":"Altiparmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"5","key":"4009_CR1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and Temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036\u201342. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.006.","journal-title":"Ophthalmology"},{"key":"4009_CR2","doi-asserted-by":"publisher","unstructured":"Haarman AEG, Enthoven CA, Willem Tideman JL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: A review and meta-analysis. Invest Ophthalmol Visual Sci. 2020;61(4). https:\/\/doi.org\/10.1167\/iovs.61.4.49.","DOI":"10.1167\/iovs.61.4.49"},{"key":"4009_CR3","doi-asserted-by":"publisher","unstructured":"Naidoo KS, Fricke TR, Frick KD, Jong M, Naduvilath TJ, Resnikoff S et al. Potential Lost Productivity Resulting from the Global Burden of Myopia: Systematic Review, Meta-analysis, and Modeling. Ophthalmology. 2019;126(3):338\u2013\u200946. https:\/\/doi.org\/10.1016\/j.ophtha.2018.10.029. PMID: 30342076.","DOI":"10.1016\/j.ophtha.2018.10.029"},{"key":"4009_CR4","doi-asserted-by":"publisher","unstructured":"Walline JJ, Lindsley KB, Vedula SS, Cotter SA, Mutti DO, Ng SM, et al. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev. 2020;1(1). https:\/\/doi.org\/10.1002\/14651858.CD004916.pub4.","DOI":"10.1002\/14651858.CD004916.pub4"},{"issue":"2","key":"4009_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the treatment of myopia 2). Ophthalmology. 2012;119(2):347\u201354. https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.031.","journal-title":"Ophthalmology"},{"key":"4009_CR6","first-page":"680","volume":"17","author":"VA Barathi","year":"2011","unstructured":"Barathi VA, Beuerman RW. Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: prior to and after induction of experimental myopia with Atropine treatment. Mol Vis. 2011;17:680\u201392.","journal-title":"Mol Vis"},{"issue":"1","key":"4009_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1001\/archophthalmol.2009.332","volume":"128","author":"D Cheng","year":"2010","unstructured":"Cheng D, Schmid KL, Woo GC, Drobe B. Randomized trial of effect of bifocal and prismatic bifocal spectacles on myopic progression: two-year results. Arch Ophthalmol. 2010;128(1):12\u20139. https:\/\/doi.org\/10.1001\/archophthalmol.2009.332.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"4009_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00006324-199906000-00013","volume":"76","author":"JT Leung","year":"1999","unstructured":"Leung JT, Brown B. Progression of myopia in Hong Kong Chinese schoolchildren is slowed by wearing progressive lenses. Optom Vis Sci. 1999;76(6):346\u201354. https:\/\/doi.org\/10.1097\/00006324-199906000-00013.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"4009_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, et al. Defocus incorporated multiple segments (Defocus incorporated multiple segments) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363\u20138. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313739.","journal-title":"Br J Ophthalmol"},{"key":"4009_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajo.2023.03.030","volume":"253","author":"X Li","year":"2023","unstructured":"Li X, Huang Y, Yin Z, Liu C, Zhang S, Yang A, et al. Myopia control efficacy of spectacle lenses with aspherical lenslets: results of a 3-Year Follow-Up study. Am J Ophthalmol. 2023;253:160\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2023.03.030.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"4009_CR11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1136\/bjo-2022-322703","volume":"107","author":"J Rappon","year":"2023","unstructured":"Rappon J, Chung C, Young G, et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). Br J Ophthalmol. 2023;107(12):1709\u201315. https:\/\/doi.org\/10.1136\/bjo-2022-322703.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"4009_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/OPX.0b013e3181ea19c7","volume":"87","author":"P Sankaridurg","year":"2010","unstructured":"Sankaridurg P, Donovan L, Varnas S, Ho A, Chen X, Martinez A, et al. Spectacle lenses designed to reduce progression of myopia: 12-month results. Optom Vis Sci. 2010;87(9):631\u201341. https:\/\/doi.org\/10.1097\/OPX.0b013e3181ea19c7.","journal-title":"Optom Vis Sci"},{"issue":"5","key":"4009_CR13","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ophtha.2023.01.007","volume":"130","author":"J Liu","year":"2023","unstructured":"Liu J, Lu Y, Huang D, Yang J, Fan C, Chen C, et al. The efficacy of defocus incorporated multiple segments lenses in slowing myopia progression: results from diverse clinical circumstances. Ophthalmology. 2023;130(5):542\u201350. https:\/\/doi.org\/10.1016\/j.ophtha.2023.01.007.","journal-title":"Ophthalmology"},{"issue":"1","key":"4009_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12886-021-02036-9","volume":"21","author":"DO Mutti","year":"2021","unstructured":"Mutti DO, Jordan LA, Zadnik K. Predicting the onset of myopia in children: results from the CLEERE study. BMC Ophthalmol. 2021;21(1):279. https:\/\/doi.org\/10.1186\/s12886-021-02036-9.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"4009_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/opo.12743","volume":"41","author":"C Truckenbrod","year":"2021","unstructured":"Truckenbrod C, Meigen C, Brandt M, Wolff C, Gaus H, Bottesch M, et al. Longitudinal analysis of axial length growth in a German cohort of healthy children and adolescents. Ophthalmic Physiol Opt. 2021;41(1):70\u20139. https:\/\/doi.org\/10.1111\/opo.12743.","journal-title":"Ophthalmic Physiol Opt"},{"key":"4009_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ajo.2023.09.022","volume":"257","author":"W Al-Thawabieh","year":"2024","unstructured":"Al-Thawabieh W, Al-Omari R, Abu-Hassan DW, et al. Tropicamide versus cyclopentolate for cycloplegic refraction in pediatric patients with brown Irides: A randomized clinical trial. Am J Ophthalmol. 2024;257:218\u201326. https:\/\/doi.org\/10.1016\/j.ajo.2023.09.022.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"4009_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391. https:\/\/doi.org\/10.3758\/BF03193146.","journal-title":"Behav Res Methods"},{"issue":"2","key":"4009_CR18","doi-asserted-by":"publisher","first-page":"e0281816","DOI":"10.1371\/journal.pone.0281816","volume":"18","author":"P Nucci","year":"2023","unstructured":"Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans BJW. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, Atropine, and combined DIMS\/atropine. PLoS ONE. 2023;18(2):e0281816. https:\/\/doi.org\/10.1371\/journal.pone.0281816.","journal-title":"PLoS ONE"},{"issue":"6","key":"4009_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","volume":"329","author":"JC Yam","year":"2023","unstructured":"Yam JC, Zhang XJ, Zhang Y, Wang YM, Chen LJ, Ko ST, et al. Effect of low-concentration Atropine Eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial. JAMA. 2023;329(6):472\u201381. https:\/\/doi.org\/10.1001\/jama.2022.24162.","journal-title":"JAMA"},{"key":"4009_CR20","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.","edition":"2"},{"key":"4009_CR21","doi-asserted-by":"publisher","first-page":"100923doi","DOI":"10.1016\/j.preteyeres.2020.100923","volume":"83","author":"NA Brennan","year":"2021","unstructured":"Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. 2021;83:100923doi. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100923.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"4009_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3341\/kjo.2022.0125","volume":"37","author":"N Erdinest","year":"2023","unstructured":"Erdinest N, London N, Lavy I, Berkow D, Landau D, Morad Y, et al. Peripheral defocus and myopia management: A Mini-Review. Korean J Ophthalmol. 2023;37(1):70\u201381. https:\/\/doi.org\/10.3341\/kjo.2022.0125.","journal-title":"Korean J Ophthalmol"},{"issue":"4","key":"4009_CR23","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1167\/iovs.02-0816","volume":"44","author":"J Gwiazda","year":"2003","unstructured":"Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, et al. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci. 2003;44(4):1492\u2013500. https:\/\/doi.org\/10.1167\/iovs.02-0816.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4009_CR24","doi-asserted-by":"publisher","unstructured":"Weise KK, Repka MX, Zhu Y, Manny RE, Raghuram A, Chandler DL et al. Baseline factors associated with myopia progression and axial elongation over 30 months in children 5 to 12 years of age. Optom Vis Sci. 2024;101(10):619\u2013626. https:\/\/doi.org\/10.1097\/OPX.0000000000002187. PMID: 39480129.","DOI":"10.1097\/OPX.0000000000002187"},{"issue":"11","key":"4009_CR25","doi-asserted-by":"publisher","first-page":"e0241759","DOI":"10.1371\/journal.pone.0241759","volume":"15","author":"PK Verkicharla","year":"2020","unstructured":"Verkicharla PK, Kammari P, Das AV. Myopia progression varies with age and severity of myopia. PLoS ONE. 2020;15(11):e0241759. https:\/\/doi.org\/10.1371\/journal.pone.0241759.","journal-title":"PLoS ONE"},{"issue":"8","key":"4009_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/bjo-2023-324508","volume":"108","author":"B Graff","year":"2024","unstructured":"Graff B, Lam CSY, Vlasak N, Kaymak H. Age-matched analysis of axial length growth in myopic children wearing defocus incorporated multiple segments spectacle lenses. Br J Ophthalmol. 2024;108(8):1060\u20136. https:\/\/doi.org\/10.1136\/bjo-2023-324508.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"4009_CR27","first-page":"120","volume":"39","author":"DO Mutti","year":"1998","unstructured":"Mutti DO, Zadnik K, Fusaro RE, Friedman NE, Sholtz RI, Adams AJ. Optical and structural development of the crystalline lens in childhood. Invest Ophthalmol Vis Sci. 1998;39(1):120\u201333.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"4009_CR28","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1167\/iovs.12-9637","volume":"53","author":"R Iribarren","year":"2012","unstructured":"Iribarren R, Morgan IG, Chan YH, Lin X, Saw SM. Changes in lens power in Singapore Chinese children during refractive development. Invest Ophthalmol Vis Sci. 2012;53(9):5124\u201330. https:\/\/doi.org\/10.1167\/iovs.12-9637.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"4009_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/00006324-200303000-00012","volume":"80","author":"K Zadnik","year":"2003","unstructured":"Zadnik K, Manny RE, Yu JA, Mitchell GL, Cotter SA, Quiralte JC, et al. The collaborative longitudinal evaluation of ethnicity and refractive error (CLEERE) study group. Ocular component data in schoolchildren as a function of age and gender. Optom Vis Sci. 2003;80(3):226.","journal-title":"Optom Vis Sci"},{"key":"4009_CR30","doi-asserted-by":"publisher","unstructured":"Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans BJW. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (Defocus incorporated multiple Segments) spectacles, Atropine, and combined defocus incorporated multiple segments\/atropine. PLoS ONE. 2023;18(2). https:\/\/doi.org\/10.1371\/journal.pone.0281816.","DOI":"10.1371\/journal.pone.0281816"},{"issue":"8","key":"4009_CR31","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/bjophthalmol-2020-318367","volume":"106","author":"J Bao","year":"2022","unstructured":"Bao J, Yang A, Huang Y, Li X, Pan Y, Ding C, et al. One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br J Ophthalmol. 2022;106(8):1171\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318367.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"4009_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/tjo.galenos.2024.17971","volume":"55","author":"N Akagun","year":"2025","unstructured":"Akagun N, Alt\u0131parmak UE. Combination therapy with Atropine 0.05% and Myopi-X\u00ae glasses: is it effective in myopia control? Turk J Ophthalmol. 2025;55(1):1\u20135. https:\/\/doi.org\/10.4274\/tjo.galenos.2024.17971.","journal-title":"Turk J Ophthalmol"},{"issue":"10","key":"4009_CR33","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jamaophthalmol.2023.2097","volume":"141","author":"K Zadnik","year":"2023","unstructured":"Zadnik K, Schulman E, Flitcroft I, et al. Efficacy and safety of 0.01% and 0.02% Atropine for the treatment of pediatric myopia progression over 3 years: A randomized clinical trial. JAMA Ophthalmol. 2023;141(10):990\u20139. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2097.","journal-title":"JAMA Ophthalmol"},{"key":"4009_CR34","doi-asserted-by":"publisher","unstructured":"Loughman J, Kobia-Acquah E, Lingham G, et al. Myopia outcome study of Atropine in children: Two-year result of daily 0.01% Atropine in a European population. Acta Ophthalmol. 2024;102(3). https:\/\/doi.org\/10.1111\/aos.15761.","DOI":"10.1111\/aos.15761"},{"issue":"7","key":"4009_CR35","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/jcm10071444","volume":"10","author":"W Myles","year":"2021","unstructured":"Myles W, Dunlop C, McFadden SA. The effect of long-term low-dose Atropine on refractive progression in myopic Australian school children. J Clin Med. 2021;10(7):1444. https:\/\/doi.org\/10.3390\/jcm10071444.","journal-title":"J Clin Med"},{"key":"4009_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/jop.2015.0043","volume":"31","author":"TY Clark","year":"2015","unstructured":"Clark TY, Clark RA. Atropine 0.01% Eyedrops significantly reduce the progression of childhood myopia. J Ocul Pharmacol Ther. 2015;31:541\u20135.","journal-title":"J Ocul Pharmacol Ther"},{"key":"4009_CR37","doi-asserted-by":"publisher","unstructured":"Sacchi M, Serafino M, Villani E, et al. Efficacy of Atropine 0.01% for the treatment of childhood myopia in European patients. Acta Ophthalmol. 2019;97(8). https:\/\/doi.org\/10.1111\/aos.14166.","DOI":"10.1111\/aos.14166"},{"key":"4009_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40123-019-0194-6","volume":"8","author":"L Joachimsen","year":"2019","unstructured":"Joachimsen L, B\u00f6hringer D, Gross NJ, Reich M, Stifter J, Reinhard T, et al. A pilot study on the efficacy and safety of 0.01% Atropine in German schoolchildren with progressive myopia. Ophthalmol Ther. 2019;8:427\u201333.","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"4009_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.oftale.2018.02.006","volume":"93","author":"M Diaz-Llopis","year":"2018","unstructured":"Diaz-Llopis M, Pinazo-Dur\u00e1n MD. Superdiluted Atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness. Arch Soc Esp Oftalmol (Engl Ed). 2018;93(4):182\u20135. https:\/\/doi.org\/10.1016\/j.oftale.2018.02.006.","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"4009_CR40","doi-asserted-by":"publisher","unstructured":"Moriche-Carretero M, Revilla-Amores R, Guti\u00e9rrez-Blanco A, Moreno-Morillo FJ, Martinez-Perez C, et al. Five-year results of Atropine 0.01% efficacy in the myopia control in a European population. Br J Ophthalmol. 2023 Jun;2. https:\/\/doi.org\/10.1136\/bjo-2022-322808.","DOI":"10.1136\/bjo-2022-322808"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04009-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04009-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04009-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T09:00:07Z","timestamp":1744880407000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04009-8"}},"subtitle":["Study design: retrospective observational study"],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4009"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04009-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a retrospective observational study. The study was approved by the Ac\u0131badem Healthcare Institutions Medical Research Ethics Committee (Ethics Approval No: 2023-21\/733). Informed consent forms were obtained from the parents\/guardians of all patients included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}